The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.00
Bid: 22.00
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.091%)
Open: 23.00
High: 23.00
Low: 23.00
Prev. Close: 23.00
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

20 Dec 2023 07:34

RNS Number : 4456X
Mission Group PLC (The)
20 December 2023

20th December 2023

The Mission Group plc

("MISSION" the "Company" or the "Group")

BUSINESS AND TRADING UPDATE

The MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies, wishes to provide a business and trading update since the Group's last update on 23 October 2023 (the "Update") for the remainder of the 2023 financial year to 31 December 2023 ("FY2023").

Trading for FY2023 is currently expected to be in line with the Board's revised outlook, as outlined in the Update.

VALUE RESTORATION PLAN

As outlined in the Update, in response to the impact of the more challenging trading conditions on the business, the Group has started to implement a "Value Restoration Plan" comprising of a series of significant cost saving initiatives, margin improvements and selected possible business disposals, to restore value to MISSION shareholders.

This plan is now well underway and a total of £5m of cost savings have been identified. An initial £2m of annualised costs savings relating to headcount reduction in certain of the Group's business units have been delivered at a cost of £0.4m. A further £3m of annualised non-agency cost savings have been targeted and are being implemented at a cost of £0.3m.

Progress has been made on the disposal of two non-core businesses in line with the Group's strategy. In each case, a letter of intent has been received. These discussions are ongoing and either, or both, of these may complete in the coming months, but at this stage there can be no certainty that they will progress to a completed transaction.

A further update on the Group's progress against the Value Restoration Plan will be provided with the FY2023 trading statement in January 2024.

FINANCIAL POSITION

Our long-standing lender, NatWest has agreed to waive the December covenant. We remain in constructive dialogue with respect to covenants and maturity of facilities and are confident that through this ongoing support from our Bank, we will have the liquidity and headroom to deliver upon our medium-term strategy.

We are actively managing our net debt position together with that of our trade and other creditors to ensure that we have as much flexibility as possible. At this stage, the Group's net debt at 31 December 2023 is expected to be unchanged from that set out in the Update, being approximately £24.0m.

ENDS

ENQUIRIES:

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

Via Houston

Simon Bridges / Andrew Potts / Harry Rees

Canaccord Genuity Limited (Nominated Adviser and Broker)

020 7523 8000

Kate Hoare / Alexander Clelland / India Spencer

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

NOTES TO EDITORS

MISSION is a collective of digital marketing and communications Agencies employing over 1,000 people across 29 locations and 3 continents. The Group successfully combines its diverse expertise to produce Work That Counts TM for Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real growth for some of the world's biggest brands. www.themission.co.uk

The person responsible for arranging the release of this announcement on behalf of MISSION is James Clifton.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTFIFVDFSLIFIV
Date   Source Headline
18th Apr 202410:00 amRNSIssue of Contingent Consideration Shares & TVR
2nd Apr 20247:00 amRNSFinal Results
28th Mar 20245:30 pmRNSFinal Results
17th Jan 20247:00 amRNSTrading Update
5th Jan 20247:00 amRNSDISPOSAL UPDATE - PATHFINDR
20th Dec 20237:34 amRNSTrading Statement
24th Nov 202312:46 pmRNSBoard Change
7th Nov 20232:47 pmRNSNotification of Major Holdings
31st Oct 20235:07 pmRNSHolding(s) in Company
31st Oct 20239:29 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSTRADING UPDATE AND REVISED OUTLOOK FOR 2023
19th Oct 20236:25 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2023
25th Sep 202310:27 amRNSNEW CONTRACT WIN
20th Sep 20239:44 amRNSInvestor Presentation
27th Jul 20237:01 amRNSTrading Update
27th Jul 20237:00 amRNSChange of Adviser
20th Jun 20232:44 pmRNSResult of AGM
20th Jun 20237:00 amRNSDirector Dealing
3rd Apr 20237:00 amRNSDividend Declaration
28th Mar 20237:00 amRNSFinal Results
24th Mar 20237:00 amRNSInvestor Presentation
16th Mar 202310:16 amRNSLaunch Of New Integrated Growth Media Agency
14th Feb 20237:00 amRNSACQUISITION OF MEZZO LABS
12th Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSACQUISITION OF INFLUENCE SPORTS & MEDIA
31st Oct 20224:39 pmRNSHolding(s) in Company
27th Sep 20227:01 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2022
27th Sep 20227:00 amRNSCHANGES TO THE BOARD
26th Aug 202210:27 amRNSHolding(s) in Company
18th Aug 202210:30 amRNSEBT Share Dealing
17th Aug 20228:45 amRNSEBT Share Dealing
15th Aug 20222:29 pmRNSEBT Share Dealing
12th Aug 20227:00 amRNSEBT Share Dealing
10th Aug 20229:00 amRNSEBT Share Dealing
8th Aug 20228:51 amRNSEBT Share Dealing
5th Aug 20229:36 amRNSEBT Share Dealing
3rd Aug 20227:00 amRNSEBT Share Dealing
25th Jul 20223:47 pmRNSEBT Share Dealing
20th Jul 20228:22 amRNSEBT Share Dealing
19th Jul 20227:00 amRNSEBT Share Purchase
15th Jul 202210:22 amRNSEBT Share Purchase
14th Jul 20229:34 amRNSEBT Share Dealing
13th Jul 20227:00 amRNSTrading Update
8th Jul 20229:02 amRNSEBT Share Dealing
5th Jul 20223:44 pmRNSEBT Share Dealing
30th Jun 20228:55 amRNSEBT Share Dealing
29th Jun 202211:54 amRNSEBT Share Dealing
21st Jun 20222:35 pmRNSResult of AGM
17th Jun 20227:00 amRNSEBT Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.